title: [Total body irradiation: techniques, dosimetry, and complications].
abstract: Total-body irradiation (TBI) has an established role in many preparative regimens used before bone marrow transplantation (BMT) in the treatment of hematological malignancies in children and adults. Better choice in TBI techniques and dosimetry have permitted better homogeneity of dose, and therefore a significant sparing of critical tissues. Advances in treatments over the past 20 years have greatly improved survival; therefore, the evaluation of early and late complications, with a sufficient follow-up, according to different conditioning regimens is important. In this article, we review and compare different TBI techniques and dosimetry, and their influence on the distribution and homogeneity of dose, and the possible relationship to the risk of complications. We also describe the acute and late effects of TBI in children and adults appearing in the first month post-BMT as veno-occlusive disease, interstitial pneumonitis, or after 3 months, i.e., endocrinal late effects and growth in children, cataracts, neurological and bone or other complications, secondary tumors and alteration in the quality of life. The responsibility of TBI in the increased rate of certain complications is difficult to assess from chemotherapy or allograft side effects (chronic graft vs. host disease) or from other associated medical treatments, such as long term steroid therapy.
authors.affiliation: Service d'oncologie-radiothérapie, centre des tumeurs, hôpital Tenon, Paris, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Belkacémi
authors.forename: B
authors.initials: B
authors.lastname: Rio
authors.forename: E
authors.initials: E
authors.lastname: Touboul
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002386:Cataract / Q000209:etiology; D002648:Child; D003131:Combined Modality Therapy; D019583:Dose Fractionation, Radiation; D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000209:etiology; D009381:Neoplasms, Radiation-Induced; D009420:Nervous System / Q000528:radiation effects; D011668:Pulmonary Veno-Occlusive Disease / Q000209:etiology; D014916:Whole-Body Irradiation / Q000009:adverse effects* / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents